Eli Lilly Buys its Way Out of Trouble-Again

Lilly settles Zyprexa suit for $1.42 billion
Lilly to pay total of $1.42 billion to settle Zyprexa suits, pleads guilty to marketing charge

Thursday January 15, 2009, 6:48 am EST
NEW YORK (AP) — Drugmaker Eli Lilly is pleading guilty to a charge that it illegally marketed anti-psychotic drug Zyprexa for off-label use, and will pay a combined $1.42 billion to settle civil suits and end the criminal investigation.

The Indianapolis-based company will pay $800 million to settle civil suits, including $438 million to the federal government and $362 million to states. It will pay $615 million to resolve the criminal probe, and plead guilty to a misdemeanor violation of the Food, Drug and Cosmetic Act for promoting Zyprexa as a dementia treatment.

The company did not acknowledge any wrongdoing in the civil cases.

Eli Lilly & Co. in October said it expected to pay $1.42 billion to end the investigations.

One response to this post.

  1. […] at Ely Lilly, 2001-Present Two weeks ago, the Psychiatric News reported “Ely Lilly Buys Its Way Out of Trouble Again. Ely Lilly paid $1.42 billion to end civil suits and a quash a criminal investigation over its […]


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: